Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
L'Encephale|March 1, 1990
[Clozapine and resistant schizophrenia]J J Pere, D Chaumet-Riffaud
Pharmacology & Toxicology|October 1, 1989
Effect of plasma protein binding on kinetics of PN 200-110 in the isolated perfused rat heartB Machard, P D Chaumet-Riffaud
Therapie|May 1, 1993
[Parlodel in early combination with levodopa in the treatment of Parkinson disease. Comparison of 2 dosage forms]F Goulley, Y Wolmark, I Bourdeix, et al.
L'Encephale|September 1, 1992
[Clozapine (Leponex) in France]J J Péré, P D Chaumet-Riffaud, I Bourdeix, et al.
Presse Medicale (Paris, France : 1983)|April 18, 1992
[Use of octreotide in the treatment of digestive endocrine tumors. A French multicenter study]M Blanchin, A James-Deidier, P D Chaumet-Riffaud, et al.
L'Encephale|January 1, 2005
[Leponex, 10 years after -- a clinical review]P M Llorca, J J Pere
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|September 18, 1979
[Alexia without agraphia, colour "agnosia" and right visual field defect: a syndrome of the posterior cerebral artery (author's transl)]J M Orgogozo, J J Pere, E Strube
Current Medical Research and Opinion|July 4, 2002
Efficacy and safety of rivastigmine in patients with Alzheimer's disease who failed to benefit from treatment with donepezilS Auriacombe, J J Pere, Y Loria-Kanza, et al.
European Neurology|March 13, 2001
Efficacy and tolerability of entacapone as adjunctive therapy to levodopa in patients with Parkinson's disease and end-of-dose deterioration in daily medical practice: an open, multicenter studyF Durif, I Devaux, J J Pere, et al.
International Journal of Clinical Practice|January 18, 2006
Rivastigmine monotherapy and combination therapy with memantine in patients with moderately severe Alzheimer's disease who failed to benefit from previous cholinesterase inhibitor treatmentT Dantoine, S Auriacombe, M Sarazin, et al.
Pageof 2